Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03269357
Other study ID # LoWe17
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2017
Est. completion date May 31, 2020

Study information

Verified date August 2020
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Training of health care providers and structured LARC forward counseling may contribute to increased LARC uptake. The hypothesis to be tested is that by introducing LARC forward counselling an increase in LARC usage will be the result as well as decreased unplanned pregnancy and abortion. It is expected that the results of this study will highlight the importance of LARC forward counseling and thus provide the evidence needed to train health care providers and increase access to LARC in youth clinics, midwifery clinics and for post abortion contraception.


Recruitment information / eligibility

Status Completed
Enrollment 1200
Est. completion date May 31, 2020
Est. primary completion date May 31, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- At risk for pregnancy (sexually active with men or anticipate becoming sexually active in the next 6 months).

- Do not desire pregnancy .

- No contraindications to LARC

Exclusion Criteria:

- Undergone tubal ligation or other sterilization procedure.

- Use of contraceptives for other purposes than contraception

Study Design


Related Conditions & MeSH terms

  • Impact of Contraceptive Counselling on LARC Uptake and Unplanned Pregnancy

Intervention

Other:
LARC forward structured contraceptive counselling
Training of health care providers (HCPs), use of information material and counselling tools

Locations

Country Name City State
Sweden WHO centre, Karolinska University Hospital Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Kristina Gemzell Danielsson

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary LARC prescriptions (recorded electronic prescriptions) The rate of women who receive a LARC prescription Evaluated at the index visit to the clinic
Secondary LARC placements recorded in patient records The rate of women who has a LARC method placed following the baseline visit Evaluated at 3months follow up (FU)
Secondary Contraceptive method used reported by participants The rate of women who use a contraceptive method Evaluated at 3,6 and 12 months FU
Secondary Satisfaction with the chosen contraceptive method reported by participants Satisfaction with the prescribed contraceptive method Evaluated at 3,6 and 12 months FU
Secondary (Unplanned) pregnancy reported by participants and recorded in patient records (Unplanned) pregnancy rate Evaluated at 3,6 and 12 months FU